What they were paid
Eton Pharmaceuticals Director Compensation Table · all 2 fiscal years held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $80,764 | — | $194,375 | — | $275,139 |
| FY2024 | $75,712 | — | $83,130 | — | $158,842 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Eton Pharmaceuticals, Inc. DEF 14A filed April 24, 2026, accession 0001437749-26-013313, and prior-year filings. Open the filing on EDGAR.
Committees
FY2025 · as the proxy prints themAudit · Compensation (Chair) · Nominating/Governance
The rest of the Eton Pharmaceuticals board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Jenn Adams | Independent Director | $267,027 |
| Norbert G. Riedel, Ph.D | Chair of the Board | $318,047 |
| Paul V. Maier | Independent Director | $277,843 |
| Sean E. Brynjelsen | Director | $0 |
The full Eton Pharmaceuticals compensation record
free company briefThis page is one director within Eton Pharmaceuticals's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat